XML 44 R31.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS COMBINATION - Narrative (Details)
3 Months Ended 6 Months Ended
Feb. 12, 2021
shares
Apr. 07, 2020
Apr. 06, 2020
USD ($)
$ / shares
shares
Mar. 09, 2020
USD ($)
contingentStockRight
$ / shares
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Business Acquisition [Line Items]                
Number of common stock shares issued per CSR (in shares)     1.2082          
Effective exchange ratio (CSR per share)     1.8006          
Share issued and delivered upon CSR conversion (in shares) | shares 18,636,103   74,544,413          
Ownership percentage of parent by subsidiary stockholders   82.00%            
Ownership percentage of parent by parent stockholders   18.00%            
Closing share price (in usd per share) | $ / shares     $ 1.40          
Goodwill impairment loss         $ 0 $ 4,500,000 $ 0 $ 4,500,000
Value of CSR converted into additional shares of the combined company       $ 19,600,000        
Contingent Stock Right Remeasurement     $ 84,700,000   0 84,726,000 0 84,726,000
Contingent consideration, fair value of liability     $ 104,400,000          
In Process Research and Development                
Business Acquisition [Line Items]                
In process research and development impairment         $ 0 $ 49,800,000 $ 0 49,800,000
Foamix                
Business Acquisition [Line Items]                
Number of contingent stock rights issued (in CSR) | contingentStockRight       1        
Closing share price (in usd per share) | $ / shares       $ 2.99        
Consideration transferred       $ 131,079,000        
Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders       $ 123,757,000        
Number of shares deemed (for accounting purposes only) issued (in shares) | shares       41,400,000        
Deemed (for accounting purposes only) conversion of Menlo equity awards       $ 7,322,000        
Value of CSR converted into additional shares of the combined company       19,600,000        
Contingent consideration, fair value of liability       $ 19,600,000        
Foamix | Employee benefits                
Business Acquisition [Line Items]                
Acquisition related costs               8,100,000
Foamix | Selling, general and administrative                
Business Acquisition [Line Items]                
Acquisition related costs               $ 11,700,000
Common stock | Foamix                
Business Acquisition [Line Items]                
Exchange ratio per ordinary share for common stock (share per share)       0.5924